Published in PLoS One on October 20, 2011
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab (2015) 1.16
Exome sequencing for the diagnosis of 46,XY disorders of sex development. J Clin Endocrinol Metab (2014) 1.12
Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol (2012) 1.12
19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. Eur J Hum Genet (2012) 1.00
Steroidogenic factor-1 and human disease. Semin Reprod Med (2012) 0.90
Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development. Orphanet J Rare Dis (2014) 0.86
Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys. Front Endocrinol (Lausanne) (2014) 0.80
The Genetic and Environmental Factors Underlying Hypospadias. Sex Dev (2015) 0.80
A novel C-terminal truncating NR5A1 mutation in dizygotic twins. Hum Genome Var (2017) 0.75
Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals. Birth Defects Res C Embryo Today (2016) 0.75
A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell (1994) 4.55
Consensus statement on management of intersex disorders. Arch Dis Child (2006) 4.07
Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature (2008) 3.44
Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet (1997) 3.40
Hypospadias: anatomy, etiology, and technique. J Pediatr Surg (2006) 2.94
A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet (1999) 2.83
Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol (1998) 2.44
Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med (2009) 1.88
A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem (1992) 1.73
Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab (2007) 1.71
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab (1998) 1.60
Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev (2008) 1.43
A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J Biol Chem (2000) 1.36
Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet (2010) 1.35
Letter: Penile size in the newborn infant. J Pediatr (1975) 1.28
Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab (1997) 1.27
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod (2007) 1.27
Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues. Mol Endocrinol (1994) 1.25
Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev (1999) 1.24
The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency. Eur J Endocrinol (2009) 1.23
A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab (2004) 1.22
Endocrine disruptors, genital development, and hypospadias. J Androl (2008) 1.22
CXorf6 is a causative gene for hypospadias. Nat Genet (2006) 1.21
Molecular aspects of steroidogenic factor 1 (SF-1). Mol Cell Endocrinol (2009) 1.16
Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab (1999) 1.15
Familial aggregation of hypospadias: a cohort study. Am J Epidemiol (2007) 1.13
FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias. Eur J Hum Genet (2007) 1.09
Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab (2010) 1.08
A mutated form of steroidogenic factor 1 (SF-1 G35E) that causes sex reversal in humans fails to synergize with transcription factor GATA-4. J Biol Chem (2003) 1.00
Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation? J Clin Endocrinol Metab (2010) 0.99
Mutational study of the MAMLD1-gene in hypospadias. Eur J Med Genet (2010) 0.89
Modulation of endogenous GATA-4 activity reveals its dual contribution to Müllerian inhibiting substance gene transcription in Sertoli cells. Mol Endocrinol (2001) 0.84
Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement--a clinical research center study. J Clin Endocrinol Metab (1996) 0.82
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99
Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor. Am J Hum Genet (2004) 3.05
Identification of mutations in CUL7 in 3-M syndrome. Nat Genet (2005) 2.10
Female epispadias management: perineal urethrocervicoplasty versus classical Young-Dees procedure. J Urol (2009) 2.04
Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr (2012) 2.02
Identification of high frequency of Y chromosome deletions in patients with sex chromosome mosaicism and correlation with the clinical phenotype and Y-chromosome instability. Am J Med Genet A (2005) 2.01
Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med (2009) 1.88
Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr (2003) 1.84
BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism. J Clin Endocrinol Metab (2002) 1.72
Re: Kim, et al. Analysis of duplicate presentations accepted at two top international pediatric urology meetings. Journal of Pediatric Urology 2012; 8: 291-5 and editorial comment by Skoog, Journal of Pediatric Urology 2012; 8: 296. J Pediatr Urol (2012) 1.69
Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics (2002) 1.62
Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J Urol (2008) 1.50
Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment. Clin Endocrinol (Oxf) (2002) 1.50
Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab (2004) 1.46
Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med (2006) 1.42
Original Koyanagi urethroplasty versus modified Hayashi technique: outcome in 57 patients. J Pediatr Urol (2009) 1.42
Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis. J Pediatr Surg (2005) 1.37
Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet (2010) 1.35
Y-chromosome analysis in Egypt suggests a genetic regional continuity in Northeastern Africa. Hum Biol (2002) 1.31
Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab (2004) 1.29
Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet (2002) 1.27
Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med (2005) 1.26
Clinical, hormonal and cytogenetic evaluation of 46,XX males and review of the literature. J Pediatr Endocrinol Metab (2005) 1.24
Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr (2004) 1.23
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr (2002) 1.22
Congenital hyperinsulinism. Early Hum Dev (2010) 1.21
An analysis of the genetic factors involved in testicular descent in a cohort of 14 male patients with anorchia. J Clin Endocrinol Metab (2004) 1.19
The Y chromosome and male fertility and infertility. Int J Androl (2003) 1.17
New clinical and therapeutic perspectives in Currarino syndrome (study of 29 cases). J Pediatr Surg (2006) 1.14
Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res (2006) 1.13
Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab (2006) 1.13
Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab (2009) 1.12
HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab (2006) 1.12
Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr (2002) 1.10
Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol (2007) 1.06
Detection of Salmonella typhi by polymerase chain reaction: implications in diagnosis of typhoid fever. Infect Genet Evol (2002) 1.05
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer (2002) 1.05
Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab (2005) 1.04
Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care (2011) 1.04
Pituitary stalk interruption syndrome: diagnostic delay and sensitivity of the auxological criteria of the growth hormone research society. PLoS One (2011) 1.03
Fetal intestinal obstruction induces alteration of enteric nervous system development in human intestinal atresia. Pediatr Res (2004) 1.02
Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study. PLoS One (2013) 1.01
Idiopathic central precocious puberty in girls: presentation factors. BMC Pediatr (2008) 1.01
Novel paralogy relations among human chromosomes support a link between the phylogeny of doublesex-related genes and the evolution of sex determination. Genomics (2002) 0.99
Self-esteem and social adjustment in young women with Turner syndrome--influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab (2006) 0.99
In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest (2011) 0.99
Lack of association between genetic polymorphisms in enzymes associated with folate metabolism and unexplained reduced sperm counts. PLoS One (2009) 0.98
Presentation and evolution of organic central precocious puberty according to the type of CNS lesion. Clin Endocrinol (Oxf) (2006) 0.97
Premature pubarche as an indicator of how body weight influences the onset of adrenarche. Eur J Pediatr (2003) 0.97
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer (2011) 0.96
Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS One (2011) 0.96
AZF microdeletions and partial deletions of AZFc region on the Y chromosome in Moroccan men. Asian J Androl (2007) 0.95
Molecular mechanisms of neonatal hyperinsulinism. Horm Res (2006) 0.94
Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency. J Clin Endocrinol Metab (2009) 0.93
Pitfalls in the diagnosis and management of obstructive uterovaginal duplication: a series of 32 cases. Pediatrics (2008) 0.93
GR/GR deletions within the azoospermia factor c region on the Y chromosome might not be associated with spermatogenic failure. Fertil Steril (2006) 0.92
Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab (2006) 0.92
Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci U S A (2011) 0.92
A deletion of a novel heat shock gene on the Y chromosome associated with azoospermia. Mol Hum Reprod (2005) 0.92
Facial appearance in persistent hyperinsulinemic hypoglycemia. Am J Med Genet (2002) 0.92
Paternal age over 40 years: the "amber light" in the reproductive life of men? J Androl (2003) 0.91
Pituitary stalk interruption syndrome in 53 postpubertal patients: factors influencing the heterogeneity of its presentation. PLoS One (2013) 0.90
Rokitansky syndrome: clinical experience and results of sigmoid vaginoplasty in 23 young girls. J Urol (2007) 0.90
Polymorphisms in MTHFR and MTRR genes associated with blood plasma homocysteine concentration and sperm counts. Fertil Steril (2011) 0.90
Quality of life determinants in young women with turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab (2005) 0.90
Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. J Clin Endocrinol Metab (2004) 0.90
Association of spermatogenic failure with the b2/b3 partial AZFc deletion. PLoS One (2012) 0.89
Improved screening for growth hormone deficiency using logical analysis data. Med Sci Monit (2009) 0.89
Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology (2009) 0.89
Diencephalic syndrome due to hypothalamic tumor: a model of the relationship between weight and puberty onset. J Clin Endocrinol Metab (2006) 0.89
The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab (2006) 0.88
Hashimoto's encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol (2012) 0.88
Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls. PLoS One (2010) 0.87